|
CYR61 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31179999482723E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.91910000510742E-08 |
| Normal-vs-Stage2 |
8.81130000074393E-08 |
| Normal-vs-Stage3 |
1.01839999988584E-07 |
| Normal-vs-Stage4 |
1.999270E-03 |
| Stage1-vs-Stage2 |
6.521600E-01 |
| Stage1-vs-Stage3 |
7.788800E-01 |
| Stage1-vs-Stage4 |
4.474000E-01 |
| Stage2-vs-Stage3 |
4.454000E-01 |
| Stage2-vs-Stage4 |
2.498000E-01 |
| Stage3-vs-Stage4 |
3.809200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00130000244303E-08 |
| Normal-vs-AfricanAmerican |
6.47139997145274E-09 |
| Normal-vs-Asian |
6.25659999999861E-05 |
| Caucasian-vs-AfricanAmerican |
7.595800E-01 |
| Caucasian-vs-Asian |
8.895200E-01 |
| AfricanAmerican-vs-Asian |
9.980800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15200000042159E-08 |
| Normal-vs-Female |
8.65469995670054E-09 |
| Male-vs-Female |
8.159800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.12559999893614E-08 |
| Normal-vs-Extreme_Weight |
1.14220000013709E-07 |
| Normal-vs-Obese |
1.62679999471393E-08 |
| Normal-vs-Extreme_Obese |
2.822400E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.822200E-01 |
| Normal_Weight-vs-Obese |
3.717000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.411800E-01 |
| Extreme_Weight-vs-Obese |
2.246400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.048600E-01 |
| Obese-vs-Extreme_Obese |
9.679400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.35339999995931E-06 |
| Normal-vs-Age(41-60Yrs) |
1.48459999849138E-08 |
| Normal-vs-Age(61-80Yrs) |
6.47419999832977E-08 |
| Normal-vs-Age(81-100Yrs) |
1.445640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.003380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.006000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.957200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.849200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.033800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.316800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.9282999974557E-08 |
| Normal-VS-Type2 PRCC |
6.43049946624785E-10 |
| Normal-VS-KIRP CIMP |
1.373910E-02 |
| Normal-VS-Unclassified PRCC |
2.20260000238781E-08 |
| Type1 PRCC-VS-Type2 PRCC |
3.855000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.624800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.568800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.483410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.910800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.901000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30439999912468E-08 |
| Normal-vs-N1 |
5.56319999955868E-07 |
| Normal-vs-N2 |
1.286760E-01 |
| N0-vs-N1 |
9.142000E-02 |
| N0-vs-N2 |
3.360800E-01 |
| N1-vs-N2 |
5.383800E-01 |
|
|
